PLEKHG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.626800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.327400E-01
Normal-vs-Stage2
7.530200E-01
Normal-vs-Stage3
9.351800E-01
Normal-vs-Stage4
7.954800E-01
Stage1-vs-Stage2
7.294400E-01
Stage1-vs-Stage3
7.263000E-01
Stage1-vs-Stage4
8.225400E-01
Stage2-vs-Stage3
8.446600E-01
Stage2-vs-Stage4
9.653000E-01
Stage3-vs-Stage4
8.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.585000E-01
Normal-vs-AfricanAmerican
5.007600E-01
Normal-vs-Asian
8.965000E-01
Caucasian-vs-AfricanAmerican
4.669200E-01
Caucasian-vs-Asian
3.937800E-01
AfricanAmerican-vs-Asian
2.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.931400E-01
Normal-vs-Female
5.656000E-01
Male-vs-Female
1.679210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.240200E-01
Normal-vs-Age(41-60Yrs)
9.411800E-01
Normal-vs-Age(61-80Yrs)
6.567800E-01
Normal-vs-Age(81-100Yrs)
5.385400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.296300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.010300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.590500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.762600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.052000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.870400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.664400E-01
Normal-vs-Daily Drinker
5.738400E-01
Normal-vs-Weekly Drinker
2.837000E-01
Normal-vs-Occasional Drinker
7.314000E-01
Normal-vs-Social Drinker
8.537000E-01
Non Drinker-vs-Daily Drinker
2.553400E-01
Non Drinker-vs-Weekly Drinker
5.035700E-02
Non Drinker-vs-Occasional Drinker
5.188800E-01
Non Drinker-vs-Social Drinker
6.663200E-01
Daily Drinker-vs-Weekly Drinker
1.534450E-01
Daily Drinker-vs-Occasional Drinker
1.072810E-01
Daily Drinker-vs-Social Drinker
6.012200E-01
Weekly Drinker-vs-Occasional Drinker
2.060100E-02
Weekly Drinker-vs-Social Drinker
1.353770E-01
Occasional Drinker-vs-Social Drinker
3.355800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.821700E-02
Normal-vs-Grade 2
1.703820E-02
Normal-vs-Grade 3
2.622600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.535200E-01
Grade 1-vs-Grade 3
8.737800E-02
Grade 1-vs-Grade 4
4.821700E-02
Grade 2-vs-Grade 3
8.996200E-03
Grade 2-vs-Grade 4
1.703820E-02
Grade 3-vs-Grade 4
2.622600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.343200E-01
Normal-vs-NonDiabetic
9.679600E-01
Diabetic-vs-NonDiabetic
9.961900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.489400E-01
Normal-vs-NoPancreatitis
8.406400E-01
Pancreatitis-vs-NoPancreatitis
4.450400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.304000E-01
Normal-vs-N1
7.201800E-01
N0-vs-N1
6.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.629200E-01
Normal-vs-TP53-NonMutant
7.421600E-01
TP53-Mutant-vs-TP53-NonMutant
6.806800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
